


Healthcare News Roundup: Drug Delivery
HSMN NewsFeed - 19 Jul 2007
Antares Announces Worldwide Development and License Agreement with Jazz Pharmaceuticals
Antares Announces Worldwide Development and License Agreement with Jazz Pharmaceuticals
HSMN NewsFeed - 9 Jul 2007
Pro-Pharmaceuticals Updates Progress of Clinical Trials & DAVANAT(R) 505 (b)(2) Filings
Pro-Pharmaceuticals Updates Progress of Clinical Trials & DAVANAT(R) 505 (b)(2) Filings
HSMN NewsFeed - 5 Jul 2007
Aradigm Corporation Names Norman Halleen as Interim Chief Financial Officer
Aradigm Corporation Names Norman Halleen as Interim Chief Financial Officer
HSMN NewsFeed - 28 Jun 2007
INVEGA(TM) Receives Marketing Authorization In European Union For Treatment Of Schizophrenia
INVEGA(TM) Receives Marketing Authorization In European Union For Treatment Of Schizophrenia
HSMN NewsFeed - 27 Jun 2007
DURECT Announces the Initiation of Sufentanil Patch Phase II Study by Endo Pharmaceuticals
DURECT Announces the Initiation of Sufentanil Patch Phase II Study by Endo Pharmaceuticals
HSMN NewsFeed - 27 Jun 2007
SurModics and Merck Enter Ophthalmic License and Research Collaboration Agreement
SurModics and Merck Enter Ophthalmic License and Research Collaboration Agreement
HSMN NewsFeed - 27 Jun 2007
YM BioSciences Receives FDA Clearance for an IND for its Fentanyl-Based Pain Product AeroLEF(TM)
YM BioSciences Receives FDA Clearance for an IND for its Fentanyl-Based Pain Product AeroLEF(TM)
HSMN NewsFeed - 26 Jun 2007
Advancis Pharmaceutical Reports on Meeting with FDA Reviewing Keflex PULSYS Phase III Trial Design
Advancis Pharmaceutical Reports on Meeting with FDA Reviewing Keflex PULSYS Phase III Trial Design
HSMN NewsFeed - 26 Jun 2007
Medical University of South Carolina Initiates New Trial of Cotara(R) in Brain Cancer Patients
Medical University of South Carolina Initiates New Trial of Cotara(R) in Brain Cancer Patients
HSMN NewsFeed - 7 Jun 2007
Patrick Gallagher Joins Acusphere as Senior Vice President, Business Development
Patrick Gallagher Joins Acusphere as Senior Vice President, Business Development
HSMN NewsFeed - 5 Jun 2007
Inovio Biomedical Stops Enrollment of Phase III Clinical Trials for Head & Neck Cancer
Inovio Biomedical Stops Enrollment of Phase III Clinical Trials for Head & Neck Cancer
HSMN NewsFeed - 5 Jun 2007
Aradigm Names D. Jeffery Grimes as General Counsel and Corporate Secretary
Aradigm Names D. Jeffery Grimes as General Counsel and Corporate Secretary
HSMN NewsFeed - 3 Jun 2007
Constab Pharmaceutical Develops New Tool to Treat Metastatic Colorectal and Other Cancers
Constab Pharmaceutical Develops New Tool to Treat Metastatic Colorectal and Other Cancers
HSMN NewsFeed - 31 May 2007
Labopharm Receives Second Approvable Letter from FDA for Once-Daily Tramadol
Labopharm Receives Second Approvable Letter from FDA for Once-Daily Tramadol
HSMN NewsFeed - 30 May 2007
Delcath Systems Receives National Cancer Institute Approval to Expand Phase III Trial to Multiple Centers
Delcath Systems Receives National Cancer Institute Approval to Expand Phase III Trial to Multiple Centers
